IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 134 filers reported holding IMMUNOGEN INC in Q4 2013. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $242,000 | -13.3% | 90,600 | 0.0% | 0.01% | -14.3% |
| Q2 2016 | $279,000 | -63.8% | 90,600 | 0.0% | 0.01% | -58.8% |
| Q1 2016 | $771,000 | -37.3% | 90,600 | 0.0% | 0.02% | -37.0% |
| Q4 2015 | $1,229,000 | +41.4% | 90,600 | 0.0% | 0.03% | +12.5% |
| Q3 2015 | $869,000 | -33.3% | 90,600 | 0.0% | 0.02% | -7.7% |
| Q2 2015 | $1,302,000 | +60.7% | 90,600 | 0.0% | 0.03% | +62.5% |
| Q1 2015 | $810,000 | +46.7% | 90,600 | 0.0% | 0.02% | +45.5% |
| Q4 2014 | $552,000 | -42.4% | 90,600 | 0.0% | 0.01% | -45.0% |
| Q3 2014 | $959,000 | -10.6% | 90,600 | 0.0% | 0.02% | +5.3% |
| Q2 2014 | $1,073,000 | -2.3% | 90,600 | +23.1% | 0.02% | -5.0% |
| Q1 2014 | $1,098,000 | +1.8% | 73,600 | 0.0% | 0.02% | +5.3% |
| Q4 2013 | $1,079,000 | -13.8% | 73,600 | 0.0% | 0.02% | -17.4% |
| Q3 2013 | $1,252,000 | +2.5% | 73,600 | 0.0% | 0.02% | 0.0% |
| Q2 2013 | $1,221,000 | – | 73,600 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 17,503,417 | $277,779,228 | 13.22% |
| Fairmount Funds Management LLC | 5,929,592 | $94,102,625 | 11.32% |
| CM Management, LLC | 500,000 | $7,935,000 | 8.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,307,435 | $20,748,993 | 6.29% |
| Altium Capital Management LP | 725,000 | $11,505,750 | 6.00% |
| RA Capital Management | 13,322,288 | $211,424,711 | 4.16% |
| TANG CAPITAL MANAGEMENT LLC | 1,500,000 | $23,805,000 | 3.36% |
| BRIDGER MANAGEMENT, LLC | 467,220 | $7,414,781 | 2.73% |
| Birchview Capital, LP | 190,000 | $3,015,300 | 2.57% |
| Boxer Capital, LLC | 2,961,000 | $46,991,070 | 2.50% |